Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2021 09:00 ET | Source: MannKind

MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021

WESTLAKE VILLAGE, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 first quarter financial results and its management will host a conference call to...
April 26, 2021 09:00 ET | Source: MannKind

MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche

Paid Off Mann Group Non-Convertible Note of $35.1 Million in Principal plus $4.4 Million in Accrued InterestPrepaid $10.0 Million Owed Under MidCap Credit Facility and Increased Borrowings Available...
April 19, 2021 06:00 ET | Source: MannKind

Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., April 19, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the...
March 16, 2021 09:00 ET | Source: MannKind

MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes

WESTLAKE VILLAGE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued an additional $30.0 million aggregate principal...
March 15, 2021 08:00 ET | Source: MannKind

MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors

WESTLAKE VILLAGE, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that it will participate in the 2022 Medicare Part D Senior Savings Model, which is...
March 10, 2021 17:00 ET | Source: MannKind

MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference

WESTLAKE VILLAGE, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
March 02, 2021 17:00 ET | Source: MannKind

MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference

WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
March 02, 2021 06:30 ET | Source: MannKind

MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering

WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the pricing of $200.0 million aggregate principal amount of 2.50% Convertible Senior...
March 01, 2021 07:00 ET | Source: MannKind

MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes

WESTLAKE VILLAGE, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it intends to offer, subject to market conditions and other factors, $150.0...
February 25, 2021 08:00 ET | Source: MannKind

MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results

Conference Call to Begin Today at 9:00 AM ET 4Q 2020 Afrezza Net Revenue of $10.1 million; +30% vs. 4Q 2019 • Sequential Quarter Growth +38% vs. 3Q 20202020 Total Revenues of $65.1 million •...